Abstract
Acute respiratory failure may develop after diffuse injury to the alveolar-capillary membrane in human and mammalian lungs following a variety of direct insults to airways or after severe systemic injury or disease. The clinical syndrome in adults usually features a latent period after the inciting event before the pathologic sequence is recognizable and progressive respiratory distress ensues; once in progress the severity of lung injury may vary, but mortality from the syndrome is appreciable in most reports. The disease entity is not new, although the current coinage — adult respiratory distress syndrome — is recent [3], and the outpouring of related research publications underscores the contemporary importance of this affliction. The designation, adult respiratory distress syndrome (ARDS), which distinguishes this syndrome from the pathologic changes found in infant hyalin membrane lung disease, conveys a dynamic interaction of clinical, radiographic, and physiologic parameters in the affected patient that mirror pathologic changes thought to be occurring in lung tissue. ARDS imparts an urgency and seriousness in its progression that automatically elicit ominous concern among the patient’s family and medical care personnel because of the morality that the diagnosis portends. It is probable that this type of lung failure was first recognized with reasonable frequency in combat casualties during World War II (1940–45). The combination of advanced surgical methods, intravenous replacement therapy plus rapid removal of the severely wounded to high-technology medical facilities salvaged many soldiers, often suffering hemodynamic shock, with greater success than ever before on battlefield circumstances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson RR, Holliday RL, Driedger AA, Lefcoe M, Reid B, Sibbald WJ: Documentation of pulmonary capillary permeability in the adult respiratory distress syndrome accompany human sepsis. Am Rev Respir Dis 119: 869–877, 1979.
Andrews CP, Coalson J J, Smith JD, Johanson WG Jr: Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest 80: 254–258, 1981.
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1: 319, 1967.
Bierman H, Kelly K, Cordes F, Byron R, Polnemus J, Rappaport S: The release of leukocytes and platelets from the pulmonary circulation by epinephrine. Blood 7: 683–692, 1952.
Bone RC, Lerner S, Stechschulte D, Murphy E, Wolfe J, Sobonya R, Hood J: Vasoactive mediators in the pathogenesis of experimental acute respiratory failure. Chest [Suppl] 75: 218–19, 1979.
Brigham KL: Factors affecting lung vascular permeability. Am Rev Respir Dis 115: 165–172, 1977.
Chand N, Altura BM: Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. Science 312: 1376–1379, 1981.
Cohen AB, Batra G, Petersen R, Podany J, NGuyen D: Size of the pool of alveolar neutrophils in normal rabbit lungs. J Appl Physiol 47: 440–444, 1979.
Cohen AB, Batra GK: Bronchoscopy and lung lavage; induced bilateral pulmonary neutrophil influx and blood leukocytosis in dogs and monkeys. Am Rev Respir Dis 122:239– 247, 1980.
Craddock PR, Hammerschmidt D, White JG, Dalmasso AP, Jacob HS: Complement (C5a)- induced granulocyte aggregation in vitro: a possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest 60: 260–264, 1977.
Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leukocytic -mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296: 769–774, 1977.
Craddock PR, Fehr J, Dalmasso AP, Birgham KL, Jacob HS: Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 879–888, 1977.
Demarest GB, Hudson LD, Altman LC: Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation. Am Rev Respir Dis 119: 279–286, 1979.
Fehr J, Jacob HS: In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. J Exp Med 146: 641–652, 1977.
Fishman AP: Shock lung: a distinctive nonentity. Circulation 47: 921, 1973.
Gadek JE, Hunninghake GW, Zimmerman RL, Crystal RG: Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor. Am Rev Respir Dis 121:723– 733, 1980.
Gillis CN, Greene NM: Possible clinical implications of metabolism of blood borne substrates by the human lung. In: Bakhle YS, Vane JR (eds) Metabolic functions of the lung. New York: Marcel Dekker, 1977, pp 173–193.
Goldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93: 597–613, 1980.
Gong H, Tierney DF: Respiratory distress syndrome: pathology and pathophysiology. In: Simmons DH (ed) Current pulmonology, vol 1. Boston: Houghton-Mifflin, 1979, pp 103–124.
Gong H, Tierney DF: Respiratory distress syndrome: use of positive end-expiratory pressure and outcome. In: Simmons DH (ed) Current pulmonology, vol 2. Boston: Houghton-Mifflin, 1980, pp 103–134.
Gorin AB, Weingarten J, Nakagawa D, Cross C: Altered lung vascular permeability in man after hemodialysis. Clin Res 29: 446A, 1981.
Green R, Zapol WM, Snider MT, Reid L, Snow R, O’Connell RS, Novelline RA: Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis 124: 593–601, 1981.
Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS:, Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome. Lancet 1: 947–949, 1980.
Hosea S, Brown E, Hammer C, Frank M: Role of complement activation in a model of adult respiratory distress syndrome. J Clin Invest 66: 375–382, 1980.
Hunninghake GW, Gadek JE, Fales M, Crystal RG: Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest 66: 473–483, 1980.
Hunninghake G, Gallin J, Fauci A: Immunologic reactivity in the lung: the in vivo and in vitro generation of a neutrophilic chemotactic factor by alveolar macrophages. Am Rev Respir Dis 117: 15–23, 1978.
Jacob HS, Craddock PR, Hammerschmidt DE, Maldow CF: Complement-induced granulocyte aggregation — an unsuspected mechanism of disease. N Engl J Med 302: 789–794, 1980.
Kaplow LS, Goffinet JA: Profound neutropenia during the early phase of hemodialysis. JAMA 203: 1135–1137, 1968.
Kazmierowski JA, Gallin JI, Reynolds HY: Mechanism for the inflammatory response in primate lungs. J Clin Invest 59: 273–281, 1977.
Leavell BS: The 9th EVAC - a history of the University of Virginia Hospital Unit in World War II. Ch 6: Care of the wounded. Richmond: Dietz, 1970, pp 101–118.
Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G: Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304: 192–196, 1981.
Lung water and solute exchange (ed NC Staub). New York: Marcel Dekker, 1978, pp 1–527.
Matthay MA, Hopewell PC: The adult respiratory distress syndrome: pathogenesis and treatment. In: Simmons DH (ed) Current pulmonology, vol 3. Boston: Houghton-Mifflin, 1981, pp 1–23.
McGuire WW, Spragg RG, Cohen AB, Cochrane: Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest 69: 543–553, 1982.
Merrill WW, Naegel GP, Matthay RA, Reynolds HY: Alveolar macrophage-derived chemotactic factor — kinetics of in vitro production and partial characterization. J Clin Invest 65: 268–276, 1980.
Murray JF, Staff of Division of Lung Diseases, National Heart, Lung and Blood Institute: Conference report: mechanisms of acute respiratory failure. Am Rev Respir Dis 115:1071 –1078,1977.
Nathan CF, Murray HW, Cohn ZA: The macrophage as an effector cell. N Engl J Med 303: 622–626, 1980.
Newball HH, Meier HL, Kaplan AP, Revak SD, Cochrane CG, Lichtenstein LM: Activation of Hageman factor by a protease released during antigen challenge of human lung. Clin Res 29:561 A, 1981.
Pennington JE, Matthews WJ Jr, Rossing TH, Gash DJ, Cole FS, Cohen HR: Local regulation of complement biosynthesis by human alveolar macrophages. Clin Res 29: 450A, 1981.
Perlo A, Jolowayski AA, Durand CM, West JB: Distribution of red and white blood cells in alveolar walls. J Appl Physiol 38: 117–124, 1975.
Propst K, Millen JE, Clauser FL: The effects of endogenous and exogenous histamine on pulmonary alveolar membrane permeability. Am Rev Respir Dis 117: 1063–1068, 1978.
Reynolds HY, Thompson RE: Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with Pseudomonas aeruginosa. J Immunol 111: 358–368, 1973.
Reynolds HY, Newball HH: Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 84: 559–573, 1974.
Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG: Analysis of cellular and protein content of bronchoalveolar lavage from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 59: 165–175, 1977.
Reynolds HY, Merrill WM, Amento EP, Naegel GP: Immunoglobulin A in secretions from the lower human respiratory tract. In: McGhee JR, Mestecky J, Babb JL (eds) Secretory immunity and infection. Advances in experimental medicine and biology, vol 107. New York: Plenum, 1978, pp 553–574.
Reynolds HY, Merrill WW: Analysis of bronchoalveolar lavage in normal humans and patients with interstitial lung diseases. In: Biserte G, Chretien J, Voisin C (eds) Proceedings international symposium of bronchoalveolar lavage in man. L’lnstitut National de la Sante et de la Recherche Medicale, vol 84: 227–250, 1979.
Reynolds HY: Human alveolar macrophages: transition from phagocytic to secretory and effector cells after a decade of research. Irwin Strasburger seminar on immunological mechanisms in pulmonary disease. New York: Grune and Stratton, 1982 (in press).
Reynolds HY, Merrill WW: Lung immunology: the inflammatory response in lung paren-chyma.In: Simmons DH (ed) Current pulmonology, vol 3. Boston: Houghton-Mifflin, pp 299–323, 1981.
Reynolds HY, Merrill WW: Airway changes in young smokers that may antedate chronic obstructive lung disease. Med Clin North Am 65: 667–689, 1981.
Rinaldo JE, Rogers RM: Adult respiratory distress syndrome - changing concepts of lung injury and repair. N Engl J Med 306: 900–909, 1982.
Robertson J, Caldwell JR, Castle JR, Waldman RH: Evidence for the presence of components of the alternate (properdin) pathway of complement activation in respiratory secretions. J Immunol 117: 900–903, 1976.
Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS: Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J Clin Invest 61: 1161–1167, 1978.
Scherzer HH, Kreutzer DL, Varanci J, Desai U, Senior RM: Demonstration of the synthesis of the third and fifth components of complement by human alveolar macrophages. Am Rev Respir Dis 121: 92A, 1980.
Schiffer CA, Aisner J, Wiernick PH: Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters. Blood 45: 141–146, 1975.
Schneider RC, Zapol WM, Carvallo AC: Plate consumption and sequestration in severe acute respiratory failure. Am Rev Respir Dis 122: 445–451, 1980.
Shaw JO, Henson J, Philips D, Henson P: Lung injury induced by intratracheal administration of a chemotactic fragment from the fifth component of complement. Am Rev Respir Dis 117: 80A, 1978.
Smith CW, Hollers JC, Patrick RA, Hassett C: Motility and adhesiveness in human neutrophils - effects of chemotactic factors. J Clin Invest 63: 221–229, 1979.
Zimmerman GA, Renzetti AD Jr, Hill HR: Circulating polymorphonuclear leukocyte activity in adult respiratory distress syndrome. Clin Res 29: 45 3A, 1981.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Reynolds, H.Y. (1982). Cellular and mediator mechanisms that contribute to lung injury in the acute respiratory distress syndrome. In: Prakash, O. (eds) Applied Physiology in Clinical Respiratory Care. Developments in Critical Care Medicine and Anaesthesiology, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7567-5_3
Download citation
DOI: https://doi.org/10.1007/978-94-009-7567-5_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7569-9
Online ISBN: 978-94-009-7567-5
eBook Packages: Springer Book Archive